BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity Management

NCT00603902 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4008

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Lorcaserin 10 mg once daily (QD)
DRUG: Lorcaserin 10 mg twice a day (BID)
DRUG: Matching Placebo

Sponsor

Eisai Inc.